Arecor Therapeutics plc announced that Susan Lowther has decided to step down from her role as Chief Financial Officer to pursue new opportunities. A search for Susan's successor is underway and her last day with Arecor is expected to be on the 22 July 2024, to ensure an effective handover.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
136.5 GBX | 0.00% | +1.11% | -25.21% |
May. 09 | Arecor Therapeutics collaborates with Medtronic on novel insulin | AN |
May. 09 | Arecor Therapeutics, Medtronic Team Up for Thermostable Insulin Development | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.21% | 52.6M | |
+29.77% | 49.18B | |
+1.00% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B |
- Stock Market
- Equities
- AREC Stock
- News Arecor Therapeutics plc
- Arecor Therapeutics plc Announces Stepping Down of Susan Lowther as Chief Financial Officer, Effective from July 22, 2024